<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628145</url>
  </required_header>
  <id_info>
    <org_study_id>HU1415-168</org_study_id>
    <nct_id>NCT02628145</nct_id>
  </id_info>
  <brief_title>Effects of a Resistance Training Program in Older Women With Sarcopenia</brief_title>
  <acronym>RESTORE-ME</acronym>
  <official_title>Effects of a Resistance Training Program in Older Women With Sarcopenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rhode Island</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rhode Island</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical trial with a control group that will test how periodized
      resistance training will impact measures of sarcopenia in older women who have been
      identified as presarcopenic or sarcopenic. The intervention will be approximately 12 weeks in
      duration with 24 total free-living older women. Outcome measures will be collected at
      baseline, 6 weeks and post-intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New sarcopenia (i.e. the age-related loss of muscle mass) guidelines established in 2014
      recommend identifying older individuals for interventions who have low muscle strength and/or
      gait speed as these functional measures are associated with low muscle mass and subsequent
      negative health consequences such as increased mortality risk. Moreover, consensus guidelines
      indicate that more research, especially in older women, needs to be conducted to test the
      efficacy of periodized (i.e. planned variations in the program) resistance exercise training
      (RT) protocols in individuals who have been identified as sarcopenic or at risk of
      sarcopenia. Our interdisciplinary research group has conducted and published the results of
      several intervention studies in older adults and would like to expand this line of research
      to fill a critical gap in the current research. The broad objective of this research project
      is to help determine the efficacy of a periodized RT intervention strategy to treat
      sarcopenia or presarcopenia and its correlates among older women. The specific primary aim is
      to determine if there is significant effect of a RT program for improving physical
      functioning and muscle mass in older women. Exploratory aims are determine the impact of the
      RT intervention on other measures including bone density, lipoproteins, and other health
      indicators. The long-term goal of this project is to generate essential data for the
      submission of a more comprehensive NIH or private agency grant. The research design will be a
      randomized trial with a control group and methodology of this study will include 25
      community-dwelling older women (age 65-84 years) for a 12-week repeated measures (baseline, 6
      week, and post) randomized study with a six month observational follow-up. After baseline
      testing, participants will be randomized to either a RT intervention group (RTI) or to an
      active control (CON) group. The RT intervention will take place three times per week on
      non-consecutive days using 8-10 exercises for major muscle groups utilizing free weights and
      machines follow American College of Sports Medicine and National Strength and Conditioning
      Association guidelines for RT in older adults. The CON group will meet three times weekly for
      light physical activity and stretching. The relevance of this research is very significant as
      no studies to date have specifically examined RT in older women who have been identified as
      sarcopenic or presarcopenic using newly established guidelines. This study will accept all
      potential participants meeting inclusion criteria, regardless of ethnic, racial, or religious
      backgrounds.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle Mass Change: From dual energy x-ray absorptiometry and bioelectrical impedance analsysis - 1) appendicular lean mass (kg) divided by height (meters-squared) and 2) appendicular lean mass divided by body mass index</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Functioning Change: normal gait speed time from 4-meter walk and 400-meter walk</measure>
    <time_frame>6 weeks, 12 weeks, and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength change: From hand grip dynamometry in kg</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sarcopenia Status Change: Established European Working Group and NIH Sarcopenia Project guidelines for 1) appendicular lean mass (aLM) divided by height (meters-sq) or aLM divided by BMI, 2) muscle strength (grip or chair stand); 3) gait speed (m/sec)</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
    <description>The multiple measurements will be aggregated to arrive at one reported value of 1) normal, 2) presarcopenia, 2) sarcopenia, or 4) sarcopenia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength change: Chest press and leg press one-repetition maximum in kg</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chair stand time change: time to complete five chair rises from a normal chair</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chair stand ability: ability to rise from a chair one time - Yes or No</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobility change: 8 foot timed up and go from a seated position around a cone back to a seated position</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Balance ability change: standing balance tests with 1) feet side to side, 2) semi-tandem, 3) full tandem, and 4) single leg. Scored as Yes or No.</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip bone mineral density: measured by dual energy x-ray absorptiometry</measure>
    <time_frame>6 weeks, 12 weeks and six month follow up</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Body mass change: measured in kg from a scale</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Height change: measured in cm from a stadiometer</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Body mass index change: weight in kg divided by height</measure>
    <time_frame>12 weeks and six month follow up</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Resistance Training Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The RT intervention will take place three times per week for approximately 12 weeks on non-consecutive days using 8-10 exercises for major muscle groups utilizing free weights and machines follow American College of Sports Medicine and National Strength and Conditioning Association guidelines for RT in older adults.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The CON group will meet three times weekly for approximately 12 weeks for light physical activity and stretching.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resistance Training Intervention</intervention_name>
    <description>The RTI group will participate in a periodized RT program on 3 non-consecutive days/week using NSCA and ACSM guidelines and will be designed by a team member who is a NSCA certified strength and conditioning specialist. This program will consist of a full-body, nonlinear periodized program: a training method that has frequent variations in program variables. Intensity variations intensity are based on training phase. E.g., the first portion of 12-week cycle has more moderate and light days as participants adapt to the program. Weeks 1-4 will consist of primarily RT machine exercises and few unilateral and multi-joint light free weight exercise. Weeks 5-8 will incorporate more free-weight exercises that are multi-joint. Weeks 9-12 will incorporate more complex multi-joint movements.</description>
    <arm_group_label>Resistance Training Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active Control Group</intervention_name>
    <description>The CON group will meet three times weekly for approximately 12 weeks for light physical activity and stretching.</description>
    <arm_group_label>Active Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women, aged 65-84 years;

          -  Low lean mass and/or low physical functioning based on current guidelines;

          -  Currently (â‰¥ 6 months) not engaged in a regular exercise program;

          -  Post-menopausal by self-report.

        Exclusion Criteria:

          -  Failure to provide informed consent;

          -  Significant or suspected cognitive impairment;

          -  Severe hearing loss, speech disorder, language barrier or visual impairment;

          -  Progressive, degenerative neurologic disease;

          -  Terminal illness with life expectancy of &lt; 12 months, as determined by a physician;

          -  Severe pulmonary disease, uncontrolled diabetes, blood pressure, or anemia;

          -  Medications not taken for &gt; 3 weeks, lipid lowering medications for &gt; 6 months;

          -  Major joint, vascular, abdominal, or thoracic surgery within six months;

          -  Significant cardiovascular disease or implanted pacemaker/defibrillator;

          -  Inability to safely engage in mild to moderate exercise with muscular exertion.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mattthew J Delmonico, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rhode Island</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rhode Island</name>
      <address>
        <city>Kingston</city>
        <state>Rhode Island</state>
        <zip>02881</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rhode Island</investigator_affiliation>
    <investigator_full_name>Matthew J. Delmonico, PhD, MPH</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>aging</keyword>
  <keyword>resistance training</keyword>
  <keyword>physical functioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

